Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Net Income towards Common Stockholders: 2018-2024

Historic Net Income towards Common Stockholders for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Dec 2024 value amounting to -$80.9 million.

  • Arcturus Therapeutics Holdings' Net Income towards Common Stockholders fell 94.81% to -$13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.7 million, marking a year-over-year decrease of 6.57%. This contributed to the annual value of -$80.9 million for FY2024, which is 172.30% down from last year.
  • According to the latest figures from FY2024, Arcturus Therapeutics Holdings' Net Income towards Common Stockholders is -$80.9 million, which was down 172.30% from -$29.7 million recorded in FY2023.
  • In the past 5 years, Arcturus Therapeutics Holdings' Net Income towards Common Stockholders ranged from a high of $9.3 million in FY2022 and a low of -$203.7 million during FY2021.
  • Its 3-year average for Net Income towards Common Stockholders is -$33.8 million, with a median of -$29.7 million in 2023.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first surged by 104.59% in 2022, then slumped by 417.95% in 2023.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Net Income towards Common Stockholders (Yearly) stood at -$71.5 million in 2020, then crashed by 184.76% to -$203.7 million in 2021, then surged by 104.59% to $9.3 million in 2022, then slumped by 417.95% to -$29.7 million in 2023, then slumped by 172.30% to -$80.9 million in 2024.